<DOC>
	<DOCNO>NCT00851279</DOCNO>
	<brief_summary>This prospective , non-randomized , multi-center clinical case series evaluate outcome magnetic navigation system ventricular tachycardia ( VT ) case . Subjects evaluate acutely follow clinically 1 , 6 12 month post-treatment .</brief_summary>
	<brief_title>Stereotaxis Study To Obliterate Persistent Ventricular Tachycardia</brief_title>
	<detailed_description>Catheter ablation ventricular tachycardia ( VT ) greatly facilitate use substrate mapping approach - , map leave ventricle sinus pace rhythm identify diseased myocardium . Using three dimensional electroanatomical mapping , possible reconstruct anatomical rendering leave ventricle base voltage . For hemodynamically stable unstable VTs , various electrophysiologic maneuver use identify critical portion VT circuit within scar ( entrainment mapping , identification diastolic potential , identification electrically-unexcitable scar , fractionate potential pace mapping ) . These method limit resolution substrate map , accuracy catheter manipulation , operator skill . To end , magnetic navigation system develop allows remote cardiac mapping . When used concert compatible electroanatomical mapping system , possible create high-density ventricular substrate map heal myocardial infarction . By remove necessity technical skill catheter manipulation , system potential improve efficacy VT ablation expand clinical use substrate mapping approach . Recently , higher-powered , irrigated tip catheter become available certain market use cardiac arrhythmia ablation . This study evaluate outcome use magnetic irrigation ablation catheter map ablation VT also use remote magnetic navigation .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>Subject must age 18 80 year Willing provide prior write informed consent per local ethic committee guideline Subjects must present ventricular tachycardia , characterize : history myocardial scar spontaneous ventricular tachycardia Able safely expose static magnetic field No insitu device present insitu device verify compatible magnetic field Presence mobile ventricular thrombus Inability access leave ventricle Subjects must contraindications shortterm anticoagulation Subjects must life expectancy &lt; 1 year due medical illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>arrhythmia</keyword>
	<keyword>ventricular tachycardia</keyword>
	<keyword>ablation</keyword>
	<keyword>mapping</keyword>
	<keyword>electrophysiology</keyword>
</DOC>